TrialJournal of virology2003

Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.

Mark Dybul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.